IRWDIronwood Pharmaceuticals, Inc.
3.485USD-0.85%Mkt Cap: 571.21M USDP/E: 5.60Last update: 2026-06-01

Ironwood Pharmaceuticals, Inc., a biotechnology company, focuses on the development and commercialization of therapies for gastrointestinal (GI) and rare diseases in the United States and internationally. It sells linacl…

Indicators:|

Key Statistics

Company
Market Cap571.21M USD
Enterprise Value964.55M USD
Revenue (TTM)361.51M USD
Gross Profit271.87M USD
Net Income (TTM)24.02M USD
Revenue/Share2.225 USD
Last Price3.485 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees100
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINUS46333X1081
Valuation
P/E (Trailing)5.60
P/E (Forward)2.48
PEG
EV/EBITDA4.73
EV/Revenue2.67
P/S1.63
P/B-2.71
EPS (TTM)0.62
EPS (Forward)1.44
52W Range
0.560056% of range5.780
52W High5.780 USD
52W Low0.5600 USD
Profitability
Gross Margin75.20%
Oper. Margin68.10%
EBITDA Margin56.40%
Profit Margin8.11%
ROE-9.17%
ROA6.05%
Growth
Revenue Growth158.90%
Earnings Growth
Cash Flow & Leverage
Operating CF127.04M USD
CapEx (TTM)34.00K USD
FCF Margin14.15%
FCF Yield8.96%
Net Debt376.89M USD
Net Debt/EBITDA1.85
Balance Sheet
Debt/Equity-2.28
Current Ratio1.41
Quick Ratio1.38
Book Value/Sh-1.3190 USD
Cash/Share1.339 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1194:1000
Split DateApr 2, 2019
Analyst Consensus
Rating
Target (Mean)6.100 USD
Target Range3.700 USD10.00 USD
# Analysts4
Ownership
Shares Out.164.61M
Float136.34M
Insiders2.93%
Institutions98.31%
Short Interest
Short Ratio7.3d
Short % Float11.51%
Short % Out.10.53%
Shares Short17.33M
Short (prev mo.)18.19M
Technical
SMA 503.820 (-8.8%)
SMA 2003.094 (+12.7%)
Beta0.30
S&P 52W Chg27.94%
Avg Vol (30d)2.27M
Avg Vol (10d)2.53M
Technical Indicators
RSI (14)39.9
MACD-0.0863
MACD Signal-0.0412
MACD Hist.-0.0451
BB Upper4.787 USD
BB Middle3.996 USD
BB Lower3.205 USD
BB Width39.58%
ATR (14)0.2625 USD
Vol Ratio (20d)0.43x